Literature DB >> 10813174

The orthopaedic management of peripheral ischaemia in meningococcal septicaemia in children.

M S Davies1, S Nadel, P Habibi, M Levin, D M Hunt.   

Abstract

Between March 1993 and February 1999, 14 children aged from eight months to 14.75 years were admitted to the paediatric intensive-care unit with meningococcal septicaemia in association with severe peripheral ischaemia. Of these, 13 were operated upon, eight of whom had early fasciotomies. Five children died. Of the nine survivors, one had no amputations while in the other eight 14 limb segments were amputated. We review the case histories and propose a protocol for the early management of these children.

Entities:  

Mesh:

Year:  2000        PMID: 10813174     DOI: 10.1302/0301-620x.82b3.9887

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  6 in total

1.  Delayed Surgical Debridement and Use of Semiocclusive Dressings for Salvage of Fingers After Purpura Fulminans.

Authors:  Paula A Pino; Javier A Román; Felipe Fernández
Journal:  Hand (N Y)       Date:  2016-08-03

2.  Meningococcal purpura fulminans in children: I. Initial orthopedic management.

Authors:  E Nectoux; A Mezel; S Raux; D Fron; M Maillet; B Herbaux
Journal:  J Child Orthop       Date:  2010-08-17       Impact factor: 1.548

3.  Purpura fulminans in probable scrub typhus group of rickettsioses from hilly region in Nepal - A case report.

Authors:  Diksha Nepal; Egesh Aryal; Suraj Parajuli; Ayush Mohan Bhattarai; Kriti Nepal; Bibhant Shah
Journal:  Ann Med Surg (Lond)       Date:  2022-09-20

Review 4.  Treatment of meningococcal infection.

Authors:  S B Welch; S Nadel
Journal:  Arch Dis Child       Date:  2003-07       Impact factor: 3.791

5.  Meningococcal disease serogroup C.

Authors:  Félix O Dickinson; Antonio E Pérez; Iván E Cuevas
Journal:  Risk Manag Healthc Policy       Date:  2012-03-08

Review 6.  Invasive Meningococcal Disease in the Vaccine Era.

Authors:  Simon Nadel; Nelly Ninis
Journal:  Front Pediatr       Date:  2018-11-09       Impact factor: 3.418

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.